Literature DB >> 14556639

Spectroscopic studies of DNA and ATP binding to human polynucleotide kinase: evidence for a ternary complex.

Rajam S Mani1, Feridoun Karimi-Busheri, Mesfin Fanta, Carol E Cass, Michael Weinfeld.   

Abstract

Human polynucleotide kinase (hPNK), which possesses both 5'-DNA kinase and 3'-DNA phosphatase activities, is a DNA repair enzyme required for processing and rejoining of single- and double-strand-break termini. Full-length hPNK was subjected to sedimentation and spectroscopic analyses in association with its ligands, a 20-mer oligonucleotide, ATP, and AMP-PNP (a nonhydrolyzable analogue of ATP). Sedimentation equilibrium measurements indicated that hPNK was a monomer in the presence and absence of the ligands. Circular dichroism measurements revealed that the ligands induced different conformational changes in hPNK, although AMP-PNP induced the same conformational changes as ATP. CD also indicated that the oligonucleotide could bind to the protein-AMP-PNP complex. Protein-ligand binding affinities and stoichiometries were determined by measuring changes in protein intrinsic fluorescence. Titrating hPNK with the oligonucleotide indicated tight binding with a K(d) value of 1.3 microM and with 1:1 stoichiometry. A 5'-phosphorylated oligonucleotide with the same sequence exhibited an almost 6-fold lower affinity (K(d) value, 7.2 microM). ATP and AMP-PNP bound with high affinity (K(d) values, respectively, of 1.4 and 1.6 microM), and the observed binding stoichiometries were 1:1. Furthermore, the nonphosphorylated oligonucleotide was able to bind to hPNK in the presence of AMP-PNP with a K(d) value of 2.5 microM, confirming the formation of a ternary complex. This study provides the first direct physical evidence for such a ternary complex involving a polynucleotide kinase, AMP-PNP, and an oligonucleotide, and supports a reaction mechanism in which ATP and DNA bind simultaneously to the enzyme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556639     DOI: 10.1021/bi030127b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors.

Authors:  N K Bernstein; F Karimi-Busheri; A Rasouli-Nia; R Mani; G Dianov; J N M Glover; M Weinfeld
Journal:  Anticancer Agents Med Chem       Date:  2008-05       Impact factor: 2.505

2.  Mechanism of action of an imidopiperidine inhibitor of human polynucleotide kinase/phosphatase.

Authors:  Gary K Freschauf; Rajam S Mani; Todd R Mereniuk; Mesfin Fanta; Caesar A Virgen; Grigory L Dianov; Jean-Marie Grassot; Dennis G Hall; Michael Weinfeld
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

3.  Unique ATPase site architecture triggers cis-mediated synchronized ATP binding in heptameric AAA+-ATPase domain of flagellar regulatory protein FlrC.

Authors:  Sanjay Dey; Maitree Biswas; Udayaditya Sen; Jhimli Dasgupta
Journal:  J Biol Chem       Date:  2015-02-16       Impact factor: 5.157

4.  Characterization of DNA Substrate Binding to the Phosphatase Domain of the DNA Repair Enzyme Polynucleotide Kinase/Phosphatase.

Authors:  Zahra Havali-Shahriari; Michael Weinfeld; J N Mark Glover
Journal:  Biochemistry       Date:  2017-03-15       Impact factor: 3.162

5.  Domain analysis of PNKP-XRCC1 interactions: Influence of genetic variants of XRCC1.

Authors:  Rajam S Mani; Inbal Mermershtain; Ismail Abdou; Mesfin Fanta; Michael J Hendzel; J N Mark Glover; Michael Weinfeld
Journal:  J Biol Chem       Date:  2018-11-16       Impact factor: 5.157

6.  Structural basis for the phosphatase activity of polynucleotide kinase/phosphatase on single- and double-stranded DNA substrates.

Authors:  Nicolas Coquelle; Zahra Havali-Shahriari; Nina Bernstein; Ruth Green; J N Mark Glover
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-14       Impact factor: 11.205

7.  Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents.

Authors:  Aghdass Rasouli-Nia; Feridoun Karimi-Busheri; Michael Weinfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

8.  The phosphatase activity of mammalian polynucleotide kinase takes precedence over its kinase activity in repair of single strand breaks.

Authors:  Caroline J Dobson; Sarah L Allinson
Journal:  Nucleic Acids Res       Date:  2006-04-28       Impact factor: 16.971

9.  Structural and functional characterization of the PNKP-XRCC4-LigIV DNA repair complex.

Authors:  R Daniel Aceytuno; Cortt G Piett; Zahra Havali-Shahriari; Ross A Edwards; Martial Rey; Ruiqiong Ye; Fatima Javed; Shujuan Fang; Rajam Mani; Michael Weinfeld; Michal Hammel; John A Tainer; David C Schriemer; Susan P Lees-Miller; J N Mark Glover
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

10.  Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor.

Authors:  Bingcheng Jiang; Cameron Murray; Bonnie L Cole; J N Mark Glover; Gordon K Chan; Jean Deschenes; Rajam S Mani; Sudip Subedi; John D Nerva; Anthony C Wang; Christina M Lockwood; Heather C Mefford; Sarah E S Leary; Jeffery G Ojemann; Michael Weinfeld; Chibawanye I Ene
Journal:  Sci Rep       Date:  2022-03-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.